Pharmacogenomics in colorectal cancer: The first step for individualized-therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

401

HTML

4221

Figures (1-5)

284

Sum=4906

Nov 28, 2007 (publication date) through Dec 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 28, 2007; 13(44): 5888-5901
Published online Nov 28, 2007. doi: 10.3748/wjg.v13.i44.5888

Full Size Figure Download Figure

Figure 2 Metabolism and mechanism of action of 5-fluoruracil (5-FU). The potential predictive markers for 5-FU response are in red-boxes.

Citation: Bandrés E, Zárate R, Ramirez N, Abajo A, Bitarte N, García-Foncillas J. Pharmacogenomics in colorectal cancer: The first step for individualized-therapy. World J Gastroenterol 2007; 13(44): 5888-5901
URL: https://www.wjgnet.com/1007-9327/full/v13/i44/5888.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i44.5888